Prostate Postbrachytherapy Seed Distribution: Comparison of High-Resolution, Contrast-Enhanced, T1- and T2-Weighted Endorectal Magnetic Resonance Imaging Versus Computed Tomography: Initial Experience

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 1, 2007, Pages 70-78

  Bloch, B Nicolas ^a,b   Lenkinski, Robert E ^a   Helbich, Thomas H ^b   Ngo, Long ^a   Oismueller, Renee ^c   Jaromi, Silvia ^b   Kubin, Klaus ^b   Hawliczek, Robert ^c   Kaplan, Irving D ^a   Rofsky, Neil M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

^c DANUBE HOSPITAL   (Austria)

Author keywords

Brachytherapy; CT; MRI; PDA; Prostate cancer; Seed dislocation

Indexed keywords

COMPUTERIZED TOMOGRAPHY; LINEAR SYSTEMS; MAGNETIC RESONANCE IMAGING; MATHEMATICAL MODELS; RADIOTHERAPY;

BRACHYTHERAPY; PROSTATE CANCER; SEED DISLOCATION;

HEALTH CARE;

ARTICLE; BLADDER; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DATA ANALYSIS; DOSIMETRY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; SEMINAL VESICLE;

BRACHYTHERAPY; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROSTATE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34547842090     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.02.039     Document Type: Article

References (49)

1. McLaughlin P.W., Narayana V., Drake D.G., et al. Comparison of MRI pulse sequences in defining prostate volume after permanent implantation. Int J Radiat Oncol Biol Phys 54 (2002) 703-711
2. Rasch C., Barillot I., Remeijer P., et al. Definition of the prostate in CT and MRI: A multi-observer study. Int J Radiat Oncol Biol Phys 43 (1999) 57-66
3. Roach III M., Faillace-Akazawa P., Malfatti C., et al. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 35 (1996) 1011-1018
4. Prete J.J., Prestidge B.R., Bice W.S., et al. Comparison of MRI- and CT-based postimplantation dosimetric analysis of transperineal interstitial permanent prostate brachytherapy. Radiat Oncol Investig 6 (1998) 90-96
5. Clarke D.H., Banks S.J., Wiederhorn A.R., et al. The role of endorectal coil MRI in patient selection and treatment planning for prostate seed implants. Int J Radiat Oncol Biol Phys 52 (2002) 903-910
6. McLaughlin P.W., Narayana V., Meriowitz A., et al. Vessel-sparing prostate radiotherapy: Dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI. Int J Radiat Oncol Biol Phys 61 (2005) 20-31
7. Dubois D.F., Prestidge B.R., Hotchkiss L.A., et al. Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. Radiology 207 (1998) 785-789
8. Coakley F.V., Hricak H., Wefer A.E., et al. Brachytherapy for prostate cancer: Endorectal MR imaging of local treatment-related changes. Radiology 219 (2001) 817-821
9. Dubois D.F., Prestidge B.R., Hotchkiss L.A., et al. Source localization following permanent transperineal prostate interstitial brachytherapy using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 39 (1997) 1037-1041
10. Servois V., Chauveinc L., El Khoury C., et al. [CT and MR image fusion using two different methods after prostate brachytherapy: Impact on postimplantation dosimetric assessment]. [French]. Cancer Radiother 7 (2003) 9-16
11. Amdur R.J., Gladstone D., Leopold K.A., et al. Prostate seed implant quality assessment using MR and CT image fusion. Int J Radiat Oncol Biol Phys 43 (1999) 67-72
12. Nag S., Ciezki J.P., Cormack R., et al. Intraoperative planning and evaluation of permanent prostate brachytherapy: Report of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 51 (2001) 1422-1430
13. Engelbrecht M.R., Jager G.J., Laheij R.J., et al. Local staging of prostate cancer using magnetic resonance imaging: A meta-analysis. Eur Radiol 12 (2002) 2294-2302
14. Bloch B.N., Rofsky N.M., Baroni R.H., et al. 3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; initial experience(1). Acad Radiol 11 (2004) 863-867
15. Schnall M.D., Imai Y., Tomaszewski J., et al. Prostate cancer: Local staging with endorectal surface coil MR imaging. Radiology 178 (1991) 797-802
16. Scheidler J., Hricak H., Vigneron D.B., et al. Prostate cancer: Localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 213 (1999) 473-480
17. Littell C.R., Milliken A.G., Stroup W.W., et al. SAS system for mixed models (1996), SAS Institute Inc, Cary, NC
18. Moerland M.A., van der Laarse R., Luthmann R.W., et al. The combined use of the natural and the cumulative dose-volume histograms in planning and evaluation of permanent prostatic seed implants. Radiother Oncol 57 (2000) 279-284
19. Moerland M.A., Wijrdeman H.K., Beersma R., et al. Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging. Int J Radiat Oncol Biol Phys 37 (1997) 927-933
20. Tiwari S.M.R., Horwitz E.M., et al. Evaluation of permanent prostate implants: A pilot study comparing dosimetric impact of inter-observer variability using CT and MRI. Int J Radiat Oncol Biol Phys (2001) 318
21. D'Amico A.V., Cormack R., Tempany C.M., et al. Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 42 (1998) 507-515
22. D'Amico A.V., Chang E., Garnick M., et al. Assessment of prostate cancer volume using endorectal coil magnetic resonance imaging: A new predictor of tumor response to neoadjuvant androgen suppression therapy. Urology 51 (1998) 287-292
23. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer. Urology 55 (2000) 572-577
24. Dubois D.F., Bice Jr. W.S., and Prestige B.R. CT and MRI derived source localization error in a custom prostate phantom using automated image coregistration. Med Phys 28 (2001) 2280-2284
25. Zaider M., Zelefsky M.J., Cohen G.N., et al. Methodology for biologically-based treatment planning for combined low-dose-rate (permanent implant) and high-dose-rate (fractionated) treatment of prostate cancer. Int J Radiat Oncol Biol Phys 61 (2005) 702-713
26. Taussky D., Haider M., McLean M., et al. Factors predicting an increased dose to the penile bulb in permanent seed prostate brachytherapy. Brachytherapy 3 (2004) 125-129
27. Wust P., von Borczyskowski D.W., Henkel T., et al. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy. Radiother Oncol 73 (2004) 39-48
28. McElveen T.L., Waterman F.M., Kim H., et al. Factors predicting for urinary incontinence after prostate brachytherapy. Int J Radiat Oncol Biol Phys 59 (2004) 1395-1404
29. Waterman F.M., and Dicker A.P. Determination of the urethral dose in prostate brachytherapy when the urethra cannot be visualized in the postimplantation CT scan. Med Phys 27 (2000) 448-451
30. Chen C.T., Waterman F.M., Valicenti R.K., et al. Dosimetric analysis of urinary morbidity following prostate brachytherapy (125I vs. 103Pd) combined with external beam radiation therapy. Int J Cancer 96 Suppl (2001) 83-88
31. 125I prostate brachytherapy. Int J Radiat Oncol Biol Phys 55 (2003) 342-353
32. Kang S.K., Chou R.H., Dodge R.K., et al. Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy. Int J Radiat Oncol Biol Phys 53 (2002) 99-103
33. Kang S.K., Chou R.H., Dodge R.K., et al. Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method. Int J Radiat Oncol Biol Phys 50 (2001) 937-945
34. Kaplan I.D., Meskell P.M., Lieberfarb M., et al. A comparison of the precision of seeds deposited as loose seeds versus suture embedded seeds: A randomized trial. Brachytherapy 3 (2004) 7-9
35. Albert M., Tempany C.M., Schultz D., et al. Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Cancer 98 (2003) 949-954
36. Kaplan I. Minimizing rectal and urinary complications in prostate brachytherapy. J Endourol 14 (2000) 381-383
37. Steenbakkers R.J., Deurloo K.E., Nowak P.J., et al. Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate. Int J Radiat Oncol Biol Phys 57 (2003) 1269-1279
38. Merrick G.S., Butler W.M., Wallner K.E., et al. The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction. Int J Radiat Oncol Biol Phys 54 (2002) 1055-1062
39. Holupka E.J., Meskell P.M., Burdette E.C., et al. An automatic seed finder for brachytherapy CT postplans based on the Hough transform. Med Phys 31 (2004) 2672-2679
40. Holupka E., Bloch B.N., Kaplan I.D., et al. Automatic seed localization, using MR images, for post implant assessment following prostate seed implantation. Radiother Oncol 71 (2004) S5-S5
41. Pickett B., Vigneault E., Kurhanewicz J., et al. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared with seven field 3-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 44 (1999) 921-929
42. Zelefsky M.J., Cohen G., Zakian K.L., et al. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging. Cancer J 6 (2000) 249-255
43. Ellis R.J., Vertocnik A., Kim E., et al. Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma. Int J Radiat Oncol Biol Phys 57 (2003) 362-370
44. Ellis R.J., Sodee D.B., Spirnak J.P., et al. Feasibility and acute toxicities of radioimmunoguided prostate brachytherapy. Int J Radiat Oncol Biol Phys 48 (2000) 683-687
45. Bloch B.N., Maril N., Haitel A., et al. Non-invasive prostate tumor volumetry using parametrically analyzed dynamic contrast enhanced MRI (DCE-MRI): Correlation with whole mount prostatectomy specimens-initial results (2005) Proceedings of the Society of Magnetic Resonance in Medicine Vol. 13 1941 (ISMRM 2005)
46. Bloch B., Furman-Haran E., Helbich T.H., et al. Accurate determination of extracapsular extension in prostate cancer using high spatial resolution dynamic contrast enhanced and T2-W magnetic resonance imaging: Initial results. Radiology (2007) in press
47. Gaston S.M., Soares M.A., Siddiqui M.M., et al. Tissue-print and print-phoresis as platform technologies for the molecular analysis of human surgical specimens: Mapping tumor invasion of the prostate capsule. Nat Med 11 (2005) 95-101
48. Potters L., Huang D., Calugaru E., et al. Importance of implant dosimetry for patients undergoing prostate brachytherapy. Urology 62 (2003) 1073-1077
49. Sosna J., Rofsky N.M., Gaston S.M., et al. Determinations of prostate volume at 3-Tesla using an external phased array coil: Comparison to pathologic specimens. Acad Radiol 10 (2003) 846-853